HSPD1 and hepatocellular carcinoma: In summary, circCCNY regulates SMURF1-mediated HSP60 ubiquitination to reduce HSP60 protein levels in HCC cells, thereby inhibiting tumor immune evasion in HCC and enhancing sensitivity to lenvatinib treatment (32).